A Study in Healthy Adults Investigating Eptinezumab Produced by 2 Different Manufacturing Cell Lines
NCT05074459
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
84
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Participants
Interventions
DRUG:
Eptinezumab Mammalian Cell Line
DRUG:
Eptinezumab Yeast Cell Line
Sponsor
H. Lundbeck A/S